Generic Abilify Maintena
Abilify Maintena (aripiprazole ER injection) is not currently available in generic form. A generic version of this drug is not expected to be available until after the exclusivity rights expire, which should occur in February 2016, provided there are no other patents in place or pending lawsuits.
Abilify Maintena™ (aripiprazole ER injection) is a prescription medication used to treat schizophrenia. It comes as a long-acting monthly injection.
Abilify Maintena is manufactured by Otsuka Pharmaceutical Co., Ltd. It is protected by exclusivity rights that prevent any generic Abilify Maintena from being manufactured in the United States.
The exclusivity rights for Abilify Maintena are currently set to expire in February 2016. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to delay or shorten this exclusivity period beyond February 2016. This could include such things as lawsuits or other patents for new Abilify Maintena uses. Once the drug goes off-patent, there may be several companies that manufacture a generic Abilify Maintena drug.
No -- aripiprazole is the active ingredient in Abilify Maintena (as well as in other forms of Abilify), not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.